Jennifer L Bailit1, William Grobman2, Yuan Zhao3, Ronald J Wapner4, Uma M Reddy5, Michael W Varner6, Kenneth J Leveno7, Steve N Caritis8, Jay D Iams9, Alan T Tita10, George Saade11, Yoram Sorokin12, Dwight J Rouse13, Sean C Blackwell14, Jorge E Tolosa15, J Peter VanDorsten16. 1. Departments of Obstetrics and Gynecology of: Case Western Reserve University-MetroHealth Medical Center, Cleveland, OH. Electronic address: jbailit@metrohealth.org. 2. Prentice Women's Hospital, Northwestern University, Chicago, IL. 3. Biostatistics Center, George Washington University, Washington, DC. 4. College of Physicians and Surgeons, Columbia University, New York, NY. 5. Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD. 6. University of Utah Health Sciences Center, Salt Lake City, UT. 7. University of Texas Southwestern Medical Center, Dallas, TX. 8. University of Pittsburgh School of Medicine, Pittsburgh, PA. 9. The Ohio State University Medical Center, Columbus, OH. 10. University of Alabama at Birmingham School of Medicine, Birmingham, AL. 11. University of Texas Medical Branch, Galveston, TX. 12. Wayne State University School of Medicine, Detroit, MI. 13. The Warren Alpert Medical School of Brown University, Providence, RI. 14. University of Texas Health Science Center at Houston-Children's Memorial Hermann Hospital, Houston, TX. 15. Oregon Health & Science University, Portland, OR. 16. Medical University of South Carolina, Charleston, SC.
Abstract
OBJECTIVE: The purpose of this study was to compare maternal and neonatal outcomes in nulliparous women with nonmedically indicated inductions at term vs those expectantly treated. STUDY DESIGN: Data were obtained from maternal and neonatal charts for all deliveries on randomly selected days across 25 US hospitals over a 3-year period. A low-risk subset of nulliparous women with vertex nonanomalous singleton gestations who delivered 38 0/7 to 41 6/7 weeks were selected. Maternal and neonatal outcomes for nonmedically indicated induction within each week were compared with women who did not undergo nonmedically indicated induction during that week. Multivariable analysis was used to adjust for hospital, maternal age, race/ethnicity, body mass index, cigarette use, and insurance status. RESULTS: We found 31,169 women who met our criteria. Neonatal complications were either less frequent with nonmedically indicated induction or no different between groups. Nonmedically indicated induction was associated with less frequent peripartum infections (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.16-0.98) at 38 weeks of gestation and less frequent third- and fourth-degree lacerations (OR, 0.60; 95% CI, 0.42-0.86) and less frequent peripartum infections (OR, 0.66; 95% CI, 0.49-0.90) at 39 weeks of gestation. Nonmedically indicated induction was associated with a longer admission-to-delivery time by approximately 3-4 hours and increased odds of cesarean delivery at 38 (OR, 1.50; 95% CI, 1.08-2.08) and 40 weeks (OR, 1.30; 95% CI, 1.15-1.46) of gestation. CONCLUSION: At 39 weeks of gestation, nonmedically indicated induction is associated with lower maternal and neonatal morbidity than women who are expectantly treated.
OBJECTIVE: The purpose of this study was to compare maternal and neonatal outcomes in nulliparous women with nonmedically indicated inductions at term vs those expectantly treated. STUDY DESIGN: Data were obtained from maternal and neonatal charts for all deliveries on randomly selected days across 25 US hospitals over a 3-year period. A low-risk subset of nulliparous women with vertex nonanomalous singleton gestations who delivered 38 0/7 to 41 6/7 weeks were selected. Maternal and neonatal outcomes for nonmedically indicated induction within each week were compared with women who did not undergo nonmedically indicated induction during that week. Multivariable analysis was used to adjust for hospital, maternal age, race/ethnicity, body mass index, cigarette use, and insurance status. RESULTS: We found 31,169 women who met our criteria. Neonatal complications were either less frequent with nonmedically indicated induction or no different between groups. Nonmedically indicated induction was associated with less frequent peripartum infections (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.16-0.98) at 38 weeks of gestation and less frequent third- and fourth-degree lacerations (OR, 0.60; 95% CI, 0.42-0.86) and less frequent peripartum infections (OR, 0.66; 95% CI, 0.49-0.90) at 39 weeks of gestation. Nonmedically indicated induction was associated with a longer admission-to-delivery time by approximately 3-4 hours and increased odds of cesarean delivery at 38 (OR, 1.50; 95% CI, 1.08-2.08) and 40 weeks (OR, 1.30; 95% CI, 1.15-1.46) of gestation. CONCLUSION: At 39 weeks of gestation, nonmedically indicated induction is associated with lower maternal and neonatal morbidity than women who are expectantly treated.
Authors: Aaron B Caughey; James M Nicholson; Yvonne W Cheng; Deirdre J Lyell; A Eugene Washington Journal: Am J Obstet Gynecol Date: 2006-09 Impact factor: 8.661
Authors: Francis P J M Vrouenraets; Frans J M E Roumen; Cary J G Dehing; Eline S A van den Akker; Maureen J B Aarts; Esther J T Scheve Journal: Obstet Gynecol Date: 2005-04 Impact factor: 7.661
Authors: Shagufta Yasmeen; Patrick S Romano; Michael E Schembri; Janet M Keyzer; William M Gilbert Journal: Am J Obstet Gynecol Date: 2006-04 Impact factor: 8.661
Authors: Judith U Hibbard; Isabelle Wilkins; Liping Sun; Kimberly Gregory; Shoshana Haberman; Matthew Hoffman; Michelle A Kominiarek; Uma Reddy; Jennifer Bailit; D Ware Branch; Ronald Burkman; Victor Hugo Gonzalez Quintero; Christos G Hatjis; Helain Landy; Mildred Ramirez; Paul VanVeldhuisen; James Troendle; Jun Zhang Journal: JAMA Date: 2010-07-28 Impact factor: 56.272
Authors: Blair G Darney; Jonathan M Snowden; Yvonne W Cheng; Lorie Jacob; James M Nicholson; Anjali Kaimal; Sascha Dublin; Darios Getahun; Aaron B Caughey Journal: Obstet Gynecol Date: 2013-10 Impact factor: 7.661
Authors: Malin Dögl; Pål Romundstad; Line Dahlgaard Berntzen; Oliv Camilla Fremgaarden; Katrine Kirial; Anne Molne Kjøllesdal; Benedicte S Nygaard; Line Robberstad; Thorbjørn Steen; Christian Tappert; Cecilie Fredvik Torkildsen; Magdalena R Vaernesbranden; Alexander Vietheer; Runa Heimstad Journal: PLoS One Date: 2018-11-29 Impact factor: 3.240
Authors: Ashley N Battarbee; Grecio Sandoval; William A Grobman; Uma M Reddy; Alan T N Tita; Robert M Silver; Yasser Y El-Sayed; Ronald J Wapner; Dwight J Rouse; George R Saade; Suneet P Chauhan; Jay D Iams; Edward K Chien; Brian M Casey; Ronald S Gibbs; Sindhu K Srinivas; Geeta K Swamy; Hyagriv N Simhan Journal: Am J Perinatol Date: 2020-04-16 Impact factor: 1.862